Slope initially began as a blog, so this is where most of the website’s content resides. Here we have tens of thousands of posts dating back over a decade. These are listed in reverse chronological order. Click on any category icon below to see posts tagged with that particular subject, or click on a word in the category cloud on the right side of the screen for more specific choices.
How to play the FOMC? Does it matter beyond “manage risk?” asked the robotic blogger.*
The Fed has been using its jawbones as well as talking out of every other orifice over the last month or two with regard to ‘taper or not to taper’. The stock market is at the moment on a tout that sees them saying ‘never mind about the taper stuff for now. We were just floating a trial balloon to prick the speculative atmosphere’. (more…)
Perhaps Consumer Reports doesn’t understand its target audience …
“We’ve long cautioned against taking quick-fix weight-loss drugs like Belviq, and Qsymia — that was also approved by the FDA last year–as well as supplements, because their benefits are usually minimal, and their adverse effects can be troublesome. Instead, skip the pills, and lose weight the safer, tried-and-true way–by eating less and exercising,” reports the well-respected organization. (more…)
This is a really impressive topping pattern…….and a firm break of $9 would send it swooning:
